Publications in collaboration with researchers from Instituto de Investigación Sanitaria Fundación Jiménez Díaz (11)

2022

  1. CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer

    Journal of Clinical Medicine, Vol. 11, Núm. 6

2021

  1. Expression of phosphorylated brd4 is markedly associated with the activation status of the pp2a pathway and shows astrong prognostic value in triple negative breast cancer patients

    Cancers, Vol. 13, Núm. 6, pp. 1-11

2017

  1. CIP2A confirms its prognostic value in triple-negative breast cancer

    Oncogene

  2. The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene

    Scientific Reports, Vol. 7

2016

  1. C-Jun N-terminal kinase inactivation by mitogen-activated protein kinase phosphatase 1 determines resistance to taxanes and anthracyclines in breast cancer

    Molecular Cancer Therapeutics, Vol. 15, Núm. 11, pp. 2780-2790

  2. Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines

    American Journal of Cancer Research, Vol. 6, Núm. 11, pp. 2661-2678

  3. Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma

    British Journal of Cancer, Vol. 115, Núm. 3, pp. 322-331

2015

  1. PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects

    Oncotarget, Vol. 6, Núm. 6, pp. 4299-4314

2014

  1. Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer

    Oncotarget, Vol. 5, Núm. 1, pp. 196-210

  2. Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer

    European Journal of Cancer, Vol. 50, Núm. 15, pp. 2725-2734

2012

  1. Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer

    Annals of Oncology, Vol. 23, Núm. 5, pp. 1156-1164